MAPKAPK2 and fatty liver disease: On the other hand, the miR8126-5p mimic inhibited the expression of the putative target gene MAPKAPK2 (−37.60% ± 2.51; p < 0.001) at the mRNA level in the in vitro model that mimicked hepatic steatosis (Figure 2A).